Pictet Asset Management (UK)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,700
Closed -$170K 1756
2021
Q1
$170K Hold
16,700
﹤0.01% 1694
2020
Q4
$124K Hold
16,700
﹤0.01% 1664
2020
Q3
$57K Buy
16,700
+6,300
+61% +$21.5K ﹤0.01% 1529
2020
Q2
$50K Buy
+10,400
New +$50K ﹤0.01% 1126